C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 235/08 (2006.01) A61K 31/415 (2006.01) A61K 31/435 (2006.01) C07D 235/06 (2006.01) C07D 401/04 (2006.01) C07D 409/04 (2006.01) C07D 417/04 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2303830
The present invention relates to compounds which inhibit tyrosine kinase enzymes, compositions which contain tyrosine kinase inhibiting compounds and methods of using tyrosine kinase inhibitors to treat tyrosine kinase-dependent diseases/conditions such as angiogenesis, cancer, atherosclerosis, diabetic retinopathy or autoimmune diseases, in mammals.
La présente invention concerne des composés inhibant les tyrosines kinases, des compositions renfermant des composés inhibant ces enzymes, et des méthodes d'utilisation des inhibiteurs des tyrosines kinases dans le traitement des maladies/états dépendant des tyrosines kinases, tels que l'angiogenèse, le cancer, l'athérosclérose, la rétinopathie diabétique ou les maladies auto-immunes, chez les mammifères.
Bilodeau Mark T.
Cunningham April M.
Hungate Randall W.
Koester Timothy J.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Novel angiogenesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel angiogenesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel angiogenesis inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1935891